Monthly Archives: April 2016

Rayno Biopharmaceuticals: New Buy Idea – Roche Plc.

Roche/Genentech Has a Strong Pipeline in Diagnostics and Therapeutics to Drive Moderate Growth in 2016 New Stock Pick: Roche Holding (RHHBY) $30.36 Over the past 3 months we recommended several new buys for the Rayno Biopharma Portfolio emphasizing moderate growth, relative safety and dividend plays. Three large cap biopharma stocks were previous picks: Abbvie (ABBV),…

AUD, NZD Fall As US Dollar Trades Mixed

Today’s Economic events Japan Monetary Base y/y 28.50% vs. 28.70% Australia MI inflation gauge m/m 0.0% vs. -0.20% previously Australia building approvals m/m 3.10% vs. 2.10% Australia retail sales m/m 0.0% vs. 0.40% ANZ Job Advertisements m/m 0.20% vs. -1.20% previously Eurozone Sentix investor confidence 5.7 vs. 6.9 Eurozone unemployment rate 10.30% vs. 10.30% UK…

AUD, NZD Fall As US Dollar Trades Mixed

Today’s Economic events Japan Monetary Base y/y 28.50% vs. 28.70% Australia MI inflation gauge m/m 0.0% vs. -0.20% previously Australia building approvals m/m 3.10% vs. 2.10% Australia retail sales m/m 0.0% vs. 0.40% ANZ Job Advertisements m/m 0.20% vs. -1.20% previously Eurozone Sentix investor confidence 5.7 vs. 6.9 Eurozone unemployment rate 10.30% vs. 10.30% UK…

E

After reporting FQ4 earnings Friday BlackBerry BBRY is slumping. The company achieved GAAP revenue of $464 million and a per share loss of $0.45. Revenue was down 30% Y/Y and off 15% sequentially; revenue was over $97 million lower than analysts expected. In FQ3 BlackBerry reported a sequential increase in revenue; I expected the company…